This one’s gonna move fast.
Welcome to Off Label. A daily news and culture brand for the 41 million Americans on a GLP-1. Five minutes. Plain English. Delivered before your pharmacist knows what happened.
This is Off Label, Not Medical Advice.
Now — into it.
TODAY'S INFO:
The GLP-1 just became a retail product.
For three years, getting on Ozempic or Wegovy meant the same ugly dance. A doctor's visit. A prior authorization. A pharmacy that was out of stock. A $900 bill. A compounded workaround that may or may not have been legal by Thursday.
That dance just ended.
This month, Amazon started selling GLP-1 pills out of a vending machine.
Not a metaphor. A literal kiosk in the lobby of your One Medical. You walk in, see a doctor, walk out with a bottle of semaglutide before you finish your coffee. If you're not in California, Amazon Pharmacy ships it to your door the same day.
The price?
$25/month with commercial insurance and a savings card
$149/month if you pay cash — or $5 a day
For context: a month of branded injectable Ozempic is still $900+. Compounded semaglutide (before the FDA shut it down in May) was $99–$269. The new pills just priced themselves below compounded — the outlaw version — and hooked themselves up to Prime logistics.
This is a retail takeover. And it started quietly.
TWO PILLS, QUIETLY AT WAR
There are two pills. They're not the same.
Wegovy pill (Novo Nordisk) — launched January. Same active ingredient as the injection: semaglutide. Proven. Decade of real-world data behind it.
Foundayo (Eli Lilly) — launched April 1. New active ingredient: orforglipron. First-ever small-molecule GLP-1. No refrigeration. No peptide chemistry. Cheaper to manufacture at scale.
They both cost the same at the starting dose. They do not behave the same.
Here's what you won't see in most coverage:
Wegovy pill | Foundayo | |
|---|---|---|
Take with food? | ❌ No. Empty stomach only | ✅ Yes. Anytime, any food |
Fasting window after? | 30 minutes of nothing | None |
Average weight loss | ~17% | ~12–13% |
Birth control interference | Minimal | Yes — during dose increases |
Refrigeration | None | None |
That last row buried in the Foundayo label? Foundayo may reduce the effectiveness of oral birth control, specifically during the first weeks of treatment and every time your dose increases. Yale Medicine flagged it. Most mainstream coverage didn't.
If you're on the pill and considering Foundayo, that's a conversation for your doctor — not a footnote.
WHY AMAZON ACTUALLY MATTERS HERE
This isn't a convenience story. It's a power shift.
1. The FDA killed compounded semaglutide in May 2025. Millions of patients who were paying $150/month through Hims, Ro, and Henry Meds got the rug pulled. Some telehealth companies pivoted to "slightly modified" versions to stay legal. Others quietly raised prices. Lilly and Novo just priced their real, branded pills at the same level the outlaws were charging — and made them available via Prime.
Translation: Big Pharma just reclaimed the cheap-GLP-1 customer.
2. CVS and Walgreens should be nervous. Amazon Pharmacy now does same-day delivery to 3,000 U.S. cities, expanding to 4,500 by year-end. The kiosks-in-clinics model means you never touch a traditional pharmacy again. Your Zepbound, your birth control, your statins — all dispensed where your doctor is, the moment they write the script.
3. The pill changes who's on GLP-1s. Tens of thousands of people avoided Ozempic because of the needle. CNBC profiled one woman who'd been afraid of injections for years. When the Wegovy pill dropped in January, she called her doctor the same day. Eleven pounds gone in the first month.
The user base is about to get a lot bigger, a lot faster, and a lot more mainstream. Expect the cultural backlash to get louder in proportion.
THE FINE PRINT NOBODY'S READING
Everything you'd want to know before you get excited:
The $25/month price requires commercial insurance that covers GLP-1s for weight loss, plus a manufacturer savings card. Many employer plans still don't cover weight-loss indications. Medicare starts at $50/month in July. Medicaid is TBD and probably slower.
Kiosks are California-only right now. Same-day delivery is nationwide. National kiosk rollout expected later in 2026.
Injections still win on weight loss. Zepbound injectable averages 21% reduction. The pills top out around 12–17%. If your goal is maximum weight loss, the needle still wins.
Both pills carry an FDA boxed warning for thyroid C-cell tumors — seen in rodents, not confirmed in humans, but the warning is real.
If you're on oral medications that require an empty stomach (levothyroxine for thyroid, omeprazole for reflux), the Wegovy pill's 30-minute fasting window creates a scheduling conflict. Foundayo doesn't.
Foundayo has drug interactions with simvastatin (common cholesterol drug) and strong CYP3A4 inhibitors. Review your full med list before starting.
THE CULTURE BEAT
Weight Watchers is now a GLP-1 distributor. WW International (the artist formerly known as Weight Watchers) is selling Foundayo through Lilly's prescribing network. The company that spent 60 years teaching you to count points just became a weight-loss drug dealer. The pivot is complete.
GoodRx is in too.
Oreo sales are reportedly falling. PepsiCo is worried enough to be restructuring snack portfolios around smaller portion sizes.
Novo Nordisk's revenue on Wegovy alone is projected to hit $18.9 billion by 2031. With $2.76 billion of that coming from the pill.
If you're wondering why every ad break now feels like a GLP-1 commercial — this is why.
WHAT'S NEXT
Tomorrow: What the Wegovy pill actually does to your stomach in week one — and the 6 foods that make it survivable.
We pulled 400+ reports from real users and built the list your doctor couldn't give you.
Hit reply and tell us what you want us to cover. Every reply is read. Story tips: [email protected]
See you in your inbox.
— Off Label
This is Off Label, Not Medical Advice. Content is for informational purposes only. Always consult a qualified healthcare provider before making medical decisions.
